Stuart Anderson is a senior contributor to Forbes who writes about immigration, business and globalization. He is the executive director of the National Foundation for American Policy, a ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...

Hogg 'should give back MBE' Disgraced Scotland rugby star Stuart Hogg is facing calls to hand back his MBE after pleading guilty to a domestic abuse charge. Hogg admitted the crime in court on ...

the strategic and the international POV from this week’s guests Stuart Stevens and Danai Gurira – take a listen above. Watch on Deadline Related Stories News 'Real Time': Michael Douglas Tells ...

New Delhi, The Delhi High Court on Tuesday ordered auctioning of the Fortis trademark in connection with the ₹3,500 crore arbitral award passed in favour of Japanese pharma major Daiichi Sankyo ...

Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...

Shares in Esperion Therapeutics lost more than half of their value after it disclosed a dispute with Daiichi Sankyo on a $300 million milestone payment relating to cholesterol drug Nexletol.

The campaign is presented by Daiichi-Sankyo and AstraZeneca, while Merck serves as a gold-level sponsor and Eli Lilly, Pfizer and Guardant come aboard as community sponsors. In the campaign’s ...

Former Australia batter Stuart Law has been sacked as coach of the men's USA national team. Law was relieved of his duties after USA's 10-wicket defeat by Scotland in a one-day international ...

A health ministry panel of experts on July 31 endorsed the plan for Daiichi Sankyo Co. to begin producing and distributing the vaccine, which creates immunity for the conventional strain of the virus.